Leukemia: Types, Symptoms and Treatment

hospital stay, admission
(Image credit: Dreamstime)

Leukemia is cancer of white blood cells that starts in the bone marrow, the soft material in the center of bones that makes white blood cells, red blood cells and platelets. 

The abnormal white blood cells in leukemia are genetically identical. They proliferate and eventually outnumber normal blood cells, interrupting their work. 

"In the blood can be such a high count of white blood cells present that it can start causing problems in the circulation. In the bone marrow, the leukemic cells overtake the bone marrow and suppress the formation of the normal blood components," said Dr. Sarah Vaiselbuh, a pediatric hematologist and oncologist at Staten Island University Hospital in New York.

As a result, "at the time of diagnosis these children or adults are often anemic and need transfusion," Vaiselbuh said. "They have very low platelet counts and are at risk of bleeding, and most importantly, their normal blood cells are no longer produced in adequate numbers, so they can't fight infection."

About 52,400 new diagnoses of leukemia are expected in the United States in 2014, and it is estimated that about 24,000 people will die of this cancer in 2014, according to the National Cancer Institute. In 2011, there were an estimated 302,800 people living with leukemia in the United States, but new leukemia cases constitute about 3 percent of all new cancer cases each year.

In children, leukemia is the most common type of cancer, but more adults get diagnosed with leukemia, according to the Leukemia and Lymphoma Society (LLS). In 2011, about nine children per 100,000 children ages 1-4 were diagnosed with leukemia. 

Survival rates for leukemia have remarkably improved over the past decades. Considering all types of leukemia in both children and adults together, in 1963, the five-year survival rate (five years after the end of treatment), was only 14 percent. But a 2009 study has found that this survival rate is now up to 59 percent, Vaiselbuh said. The progress shows the importance of continued support for leukemia research, she said.

Types of leukemia

There are four categories of leukemia based on how quickly the disease progresses (acute or chronic), and the kind of white blood cell that is affected (myeloid cells or lymphoid cells):

  • Acute, meaning the disease worsens rapidly and requires quick, potent treatment. Abnormal cells are immature blood cells called blasts, which cannot function correctly.
  • Chronic, meaning the disease progresses slowly and may not produce any initial symptoms. Abnormal cells are mature blood cells that can function normally for a period of time.
  • Myelogenous leukemia begins in the myeloid cells deep in the bone marrow. Myeloid cells normally produce red and white blood cells as well as platelets, which help clot blood.
  • Lymphocytic leukemia affects lymphoid cells, which form the immune system's lymph tissue throughout the body. 

Different types of leukemia affect different types of patients. For example, both chronic myelogenous leukemia (CML) and chronic lymphocytic leukemia (CLL) affect mostly adults, according to the National Cancer Institute. Sometimes patients may not even have symptoms and discover they have leukemia when a routine blood test shows a very high count of white blood cells, Vaiselbuh said.

Acute lymphocytic leukemia (ALL) is the most common type in young children, and acute myelogenous leukemia (AML) occurs in both adults and children.


Initial symptoms of leukemia mimic those of several other conditions, including the flu, and can be easy to overlook. According to the LLS, common symptoms include:

  • Chills, fever or night sweats
  • Persistent weakness and fatigue
  • Shortness of breath upon exertion
  • Pale skin
  • Pinhead-sized red dots under the skin
  • Unexplained bruises
  • Slow-healing cuts and excess bleeding
  • Joint or bone aches
  • Swollen lymph nodes


Leukemia is often diagnosed when a patient's blood test shows signs of the disease and prompts additional testing. 

For example, when a child with symptoms like unexplained fevers or bruises on the skin is taken to a pediatrician, the doctor will do a blood count test and may found very high white blood cells, which suggest the child might have leukemia. To confirm the diagnoses, doctors will do a biopsy of the bone marrow to look for abnormal cells, Vaiselbuh said.


Treatment for leukemia depends on the type of leukemia and other factors such as the patient's age, white blood cell count and genetics of the cancer.

The main treatment is chemotherapy, which involves injecting a combination of drugs in the blood and sometimes in the spinal fluid. 

If patient's cancer comes back after chemotherapy, doctors may consider bone marrow transplantation. They will screen the patient's sibling or the bone marrow register to find a donor who matches with the patient, Vaiselbuh said. A bone marrow transplantation replaces the diseased bone marrow by the healthy bone marrow of the donor to eradicate the disease, Vaiselbuh said.

Additional treatments may involve radiation therapy and immunotherapy, according to the American Cancer Society.

In chronic myelogenous leukemia, or CML, scientists have identified a genetic mutation involved in the disease. A drug has been developed that specifically targets the mutation and by taking the medication daily, the cancer can be kept under control, Vaiselbuh said.

Acute lymphocytic leukemia, or ALL, is the most common leukemia in children and has the highest survival rates — more than 90 percent for children under 5 years old and 66.4 percent for patients of all ages, according to the National Cancer Institute.


There is no known way to prevent most types of leukemia, especially among children, according to the American Cancer Society and the National Cancer Institute. People who have been treated for another cancer with radiation and chemotherapy, or those who are taking drugs that suppress the immune system, as well as people with certain genetic conditions such as Down's syndrome are at higher risk of developing acute leukemia, according to the Centers for Disease Control Prevention.

Additional resources

Bahar Gholipour
Staff Writer
Bahar Gholipour is a staff reporter for Live Science covering neuroscience, odd medical cases and all things health. She holds a Master of Science degree in neuroscience from the École Normale Supérieure (ENS) in Paris, and has done graduate-level work in science journalism at the State University of New York at Stony Brook. She has worked as a research assistant at the Laboratoire de Neurosciences Cognitives at ENS.